Prospective Observational Study with adult patients receiving treatment with Dupixent for atopic dermatitis. OBS15990
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: SANOFI AVENTIS GROUP
- Execution start: 29/06/2021
- End of execution: 30/09/2026
- PI: RICARDO RUIZ VILLAVERDE